Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Sexually Transmitted Diseases

  Free Subscription


Articles published in J Natl Cancer Inst

Retrieve available abstracts of 17 articles:
HTML format



Single Articles


    May 2022
  1. HU SY, Kreimer AR, Porras C, Guillen D, et al
    Performance of cervical screening a decade following HPV vaccination: The Costa Rica Vaccine Trial.
    J Natl Cancer Inst. 2022 May 31. pii: 6596052. doi: 10.1093.
    PubMed     Abstract available


  2. LALONDE CS, Teng Y, Burtness BA, Ferris RL, et al
    The Quest to Eradicate HPV-Related Oropharyngeal Carcinoma: An Opportunity Not to Miss.
    J Natl Cancer Inst. 2022 May 14. pii: 6585900. doi: 10.1093.
    PubMed     Abstract available


    February 2022
  3. HUEPENBECKER SP, Meyer LA
    How Can We Pursue Equity in Cervical Cancer Prevention with Existing HPV Genotype Differences?
    J Natl Cancer Inst. 2022 Feb 17. pii: 6530293. doi: 10.1093.
    PubMed    


  4. MIX J, Saraiya M, Hallowell BD, Befano B, et al
    Cervical Precancers and Cancers Attributed to HPV Types by Race and Ethnicity: Implications for Vaccination, Screening, and Management.
    J Natl Cancer Inst. 2022 Feb 17. pii: 6530292. doi: 10.1093.
    PubMed     Abstract available


    November 2021
  5. CORREDOR G, Toro P, Koyuncu C, Lu C, et al
    An Imaging Biomarker of Tumor-Infiltrating Lymphocytes to Risk-Stratify Patients with HPV-Associated Oropharyngeal Cancer.
    J Natl Cancer Inst. 2021 Nov 29. pii: 6446037. doi: 10.1093.
    PubMed     Abstract available


    July 2021
  6. DEHLENDORFF C, Baandrup L, Kjaer SK
    Real-World Effectiveness of Human Papillomavirus Vaccination Against Vulvovaginal High-Grade Precancerous Lesions and Cancers.
    J Natl Cancer Inst. 2021;113:869-874.
    PubMed     Abstract available


    June 2021
  7. BURTNESS B, Contessa J
    Hypoxia-Guided Therapy for Human Papillomavirus-Associated Oropharynx Cancer.
    J Natl Cancer Inst. 2021;113:652-653.
    PubMed    


  8. DESHMUKH AA, Suk R, Shiels MS, Damgacioglu H, et al
    Incidence Trends and Burden of Human Papillomavirus-Associated Cancers Among Women in the United States, 2001-2017.
    J Natl Cancer Inst. 2021;113:792-796.
    PubMed     Abstract available


    April 2021
  9. CAMPOS NG, Chaturvedi AK, Kreimer AR
    Real-World HPV Vaccine Effectiveness Studies: Guideposts for Interpretation of Current and Future Studies.
    J Natl Cancer Inst. 2021 Apr 20. pii: 6227604. doi: 10.1093.
    PubMed    


  10. KJAER SK, Dehlendorff C, Belmonte F, Baandrup L, et al
    Real-world Effectiveness of Human Papillomavirus Vaccination Against Cervical Cancer.
    J Natl Cancer Inst. 2021 Apr 20. pii: 6227603. doi: 10.1093.
    PubMed     Abstract available


    August 2020
  11. ROSSI PG, Carozzi F, Ronco G, Allia E, et al
    p16/ki67 and E6/E7 mRNA accuracy and prognostic value in triaging HPV DNA-positive women.
    J Natl Cancer Inst. 2020 Aug 3. pii: 5879994. doi: 10.1093.
    PubMed     Abstract available


    March 2020
  12. CHARI NS, Ivan C, Le X, Li J, et al
    Disruption of TP63-miR-27a* Feedback Loop by Mutant TP53 in Head and Neck Cancer.
    J Natl Cancer Inst. 2020;112:266-277.
    PubMed     Abstract available


    February 2020
  13. TSANG SH, Sampson JN, Schussler J, Porras C, et al
    Durability of Cross-Protection by Different Schedules of the Bivalent HPV Vaccine: the CVT Trial.
    J Natl Cancer Inst. 2020 Feb 24. pii: 5753954. doi: 10.1093.
    PubMed     Abstract available


  14. KREIMER AR, Sampson JN, Porras C, Schiller JT, et al
    Evaluation of durability of a single-dose of the bivalent HPV vaccine: the CVT Trial.
    J Natl Cancer Inst. 2020 Feb 24. pii: 5753955. doi: 10.1093.
    PubMed     Abstract available


  15. QIAO YL, Wu T, Li RC, Hu YM, et al
    Efficacy, Safety, and Immunogenicity of an Escherichia coli-Produced Bivalent Human Papillomavirus Vaccine: An Interim Analysis of a Randomized Clinical Trial.
    J Natl Cancer Inst. 2020;112:145-153.
    PubMed     Abstract available


    November 2019
  16. BEATY BT, Moon DH, Shen CJ, Amdur RJ, et al
    PIK3CA mutation in HPV-associated OPSCC patients receiving deintensified chemoradiation.
    J Natl Cancer Inst. 2019 Nov 20. pii: 5634148. doi: 10.1093.
    PubMed     Abstract available


  17. TOTA JE, Struyf F, Sampson JN, Gonzalez P, et al
    Efficacy of the AS04-adjuvanted HPV-16/18 vaccine: Pooled analysis of the Costa Rica Vaccine and PATRICIA randomized controlled trials.
    J Natl Cancer Inst. 2019 Nov 7. pii: 5614431. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Sexually Transmitted Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: